Calcutta Medical College, officially Medical College and Hospital, Kolkata, is a public medical school and hospital in Kolkata, West Bengal, India. It is the oldest existing hospital in Asia. The institute was established on 28 January 1835 by Lord William Bentinck during British Raj as Medical College, Bengal.It is the second oldest medical college to teach Western medicine in Asia after Ecole de Médicine de Pondichéry and the first institute to teach in English language. The hospital associated with the college is the largest hospital in West Bengal. The college offers MBBS degree after five and a half years of medical training.
Traumatic brain injury (TBI) incidents bring drastic health adversities in multiple systems of the body. The immediate impact on the head and central nervous system is promptly accelerated to the autonomous and peripheral nervous system. It causes an instant variability in intracranial pressure, heart rate, blood pressure, normal function of chemo/baro receptors, and sudden failure in normal communication. These effects promote long-term secondary health adversity, such as nerve schwannoma, gliosis, Wallerian degeneration, mitochondrial dysfunction, change in blood-brain barrier pathology, and impaired drainage of cerebrospinal fluid. The focal and diffuse character of TBI has a primary effect on the auditory system in terms of outer, middle, and inner ear damage. Auditory nerve dysfunction, central auditory miscommunication with the brain, intracanalicular vestibular schwannomas, lesions in cortical regions, hair cell damage, and spiral ganglion injury cause long-term secondary consequences on normal hearing function associated with TBI. In this present work, normal hearing impairment due to TBI-induced nerve damage, central-peripheral auditory dysfunction, long-term hearing loss, and associated other health impacts are highlighted.
The significant rise in stone disease has led to an increased popularity of percutaneous nephrolithotomy for the management of substantial stone burdens. Despite ongoing advancements in technology and surgical methods, overall complication rates of PCNL have gone up. For the best decision-making and well-informed patient counselling, a precise assessment of treatment success is essential. CT scans offer high-resolution spatial imaging that precisely characterizes stone size and distribution, pelvicaliceal anatomy, anomalies, and anatomical relationships. With these measurable stone and patient features, the Guy's Stone Score, S.T.O.N.E. score and CROES nephrolithometric nomograms have been introduced for systematic and quantitative assessment of kidney stones. There is no study evaluating the efficacy of these three scoring systems in patients undergoing supine PCNL. We prospectively analysed 100 patients over a period of 20 months (December 2022-July 2024). Analysis of relationship between residual calculus, Procedure Time (PT), Scope Time (ST), Fluoroscopy Time (FT) and duration of hospital stay and complications with different nephrolithometric scoring was done. ROC curve was drawn comparing all three scores. AUC for GSS is 0.711, STONE score is 0.705, and CROES score is 0.772 for predicting stone clearance. However, CROES score had highest sensitivity 97.3 but specificity and NPV of GSS is highest for predicting stone clearance with accuracy of 71.58%. For predicting complications AUC for GSS is 0.678, STONE score is 0.537, and CROES score is 0.591. Sensitivity of CROES is 95.7% but PPV, NPV, and accuracy is highest for Guy's stone score but data is insignificant. SFR in our study was 63%. SFR corroborated significantly with low Guy's score, low STONE score, and high CROES score. All three nomograms have statistically significant correlation with SFR. Except CROES Score, other two Scores have statistically significantly correlation with complications.
Background Users often regard the 2022 WHO verbal autopsy (VA) instrument as lengthy and time-consuming to implement, emphasising the need for a more concise and practical tool, particularly for use in unstable or resource-limited settings. This study aimed to develop, pilot test and validate an abridged version of the WHO VA instrument capable of identifying probable causes of neonatal (0–27 days), child (1 month–11 years) and adult (12–49 years) deaths in vulnerable populations.Methods An abridged VA instrument based on the expert algorithm method was developed and applied to deaths recorded between 2021 and 2022 in three tertiary general hospitals and one tertiary paediatric hospital in Kolkata, West Bengal. VA interviews were conducted between July 2024 and January 2025. Causes of death were assigned using two approaches: (1) underlying medical record diagnoses and (2) a hierarchical computer-based VA algorithm. Diagnostic metrics were used to validate algorithmic causes against medical diagnoses.Results Among 270 deaths (90 per age group), 95.5% yielded a VA diagnosis. Among neonates, the leading causes were sepsis (34.4%: 83.8% VA sensitivity, 94.9% VA specificity), IPRE (25.6%: 69.6%, 97.0%) and pneumonia (16.7%: 100%, 98.7%). Among children, the two most common medical diagnoses were pneumonia (53.3%: 100%, 50%) and other infections including sepsis without a known source (25.6%: 21.7%, 98.5%). Among adults, the two most common medical diagnostic categories were acute febrile illness (38.5%: 80.9%, 98.6%) and cardiovascular diseases (38.5%: 100%, 98.6%). The accuracy of the new VA instrument compared with the medical diagnosis was 81.1% for neonates, 71.1% for children and 87.8% for adults, with an overall accuracy of 80%.Conclusion The abridged VA instrument demonstrated satisfactory accuracy in identifying the probable causes of death across all age groups in the study populations. This instrument holds potential for enhancing cause-of-death reporting in resource-limited settings.
Fanconi anemia (FA) is a rare congenital disease associated with chromosomal instability, bone marrow failure, congenital anomalies, and predisposition to malignancies. It results primarily from mutations in genes of the Fanconi anemia/breast cancer-associated (FA/BRCA) DNA repair pathway. This pathway repairs defect in interstrand crosslink (ICL). FA shows an autosomal recessive inheritance in most cases, though other variants also exist. Clinically, FA manifests as pancytopenia, growth retardation, and skeletal malformations. These patients carry a significantly increased risk of development of acute myeloid leukemia and squamous cell carcinomas. Here we review the mechanisms involved in pathophysiology of FA. Understand the epidemiology and inheritance patterns of Fanconi anemia. Describe the clinical manifestations including hematological and non-hematological features in brief. Explain the molecular mechanisms underlying defective DNA repair in FA. Appreciate the implications of genotype–phenotype correlations and cancer predisposition.